SCHEMBL3603678

SCHEMBL3603678

CCN(C(=O)Cn1c(C(=O)OC)cc2ccc(-c3ccc(C)cc3)cc21)N(C)C1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 2/20 0.35
TSPO P30536 2/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NOD2 Q9HC29 1/20 0.35
NOD1 Q9Y239 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
TSHR P16473 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3609350 0.90 GPR35 (0.39) ALDH1A1TSPOKMT2A
SCHEMBL3603676 0.80 MTNR1A (0.40) ALDH1A1NPSR1GAAL3MBTL1MTNR1A
SCHEMBL3603674 0.74 MTNR1A (0.41) NPSR1GAAL3MBTL1MTNR1AMTNR1B
SCHEMBL13115992 0.71 HPGD (0.38) ALDH1A1NPSR1GAATSHRKDM4E
SCHEMBL3591125 0.71 KDM4E (0.42) ALDH1A1NPSR1TSHRKDM4EGRIN1
SCHEMBL3599501 0.71 GPR35 (0.38) ALDH1A1NPSR1GAATSHRKDM4E
SCHEMBL3600547 0.70 KDM4E (0.41) ALDH1A1NPSR1TSHRKDM4EGRIN1
SCHEMBL3609348 0.65 NPC1 (0.40) ALDH1A1TSHRKDM4ELMNA
SCHEMBL3604305 0.64 NTSR1 (0.36) ALDH1A1NPSR1TSHRKDM4EGRIN1
SCHEMBL7218114 0.63 NOD2 (0.52) ALDH1A1NPSR1GAAL3MBTL1NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 ALDH1A1 662/4885NPSR1 2297/4885TSPO 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.